New Developments in Retinal Pharmacotherapy

Can anti-VEGF Therapy Cause Glaucoma?

Can anti-VEGF Therapy Cause Glaucoma?

I think everyone is well aware that when you inject anti-VEGF..…

Expiration Date: 6/26/2014

Max Credits: 0

View Activity

Bevacizumab, Ranibizumab, and Stroke

Bevacizumab, Ranibizumab, and Stroke

If there's an increase of 1% rate of cardiovascular risks..…

Expiration Date: 6/19/2014

Max Credits: 0

View Activity

Ocriplasmin in Clinical Practice: How and When to Use It

Ocriplasmin in Clinical Practice: How and When to Use It

We have a new class of drug, a new pharmaceutical, a new type of indicatio…

Expiration Date: 6/11/2014

Max Credits: 0

View Activity

Vitreolysis: Rationale and Clinical Trials

Vitreolysis: Rationale and Clinical Trials

There are two broad categories of vitreolytic agents..…

Expiration Date: 6/10/2014

Max Credits: 0

View Activity

Retinal Pharmacology: Drugs, Devices, and Delivery Systems

Retinal Pharmacology: Drugs, Devices, and Delivery Systems

My task is to talk about retinal pharmacology, specifically about the drug…

Expiration Date: 5/15/2014

Max Credits: 0

View Activity

Management of Diabetic Macular Edema: The Therapeutic Paradigm Shift Continues

Management of Diabetic Macular Edema: The Therapeutic Paradigm Shift Continues

I am going to talk about the management of diabetic macular edema and how …

Expiration Date: 5/14/2014

Max Credits: 0

View Activity

Management of Wet Macular Degeneration: Treatment Challenges

Management of Wet Macular Degeneration: Treatment Challenges

We have four big trails that have compared various anti-VEGF agents..……

Expiration Date: 5/13/2014

Max Credits: 0

View Activity

Updates on the Management of Macular Edema Secondary to Vein Occlusion

Updates on the Management of Macular Edema Secondary to Vein Occlusion

I am going to be doing a round up of the clinical trial data on RVO therap…

Expiration Date: 5/12/2014

Max Credits: 0

View Activity

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

On the Scene at ARVO: Interview with Baruch D. Kuppermann, MD, PhD

A single intravitreal dose of 125 µg of ocriplasmin achieved resolution of…

Expiration Date: 5/17/2015

Max Credits: 0

View Activity

Top Ten Findings from the Comparison of AMD Treatment Trials (CATT)

Top Ten Findings from the Comparison of AMD Treatment Trials (CATT)

I think all of you know that the design of CATT..…

Expiration Date: 3/24/2014

Max Credits: 0

View Activity